Diskussionsleiter: A. Elsässer (Oldenburg), C. Weiß (Lüneburg)
| (P1797) | Technological, procedural and patient characteristics determine the risk for silent cerebral lesions in patients undergoing atrial fibrillation ablation | |
| J. Krug, A. Schade, K. Nentwich, T. Deneke, G.-A. Szöllösi, R. Schmitt, P. Bansmann, M. Horlitz, S. Kerber (Bad Neustadt a. d. Saale, Köln) | ||
| (P1798) | Association of left atrial remodeling assessed via low-voltage map and incidence of silent cerebral lesions after catheter ablation of atrial fibrillation. | |
| P. Müller, F. Schiedat, J. Dietrich, K. Nentwich, A. Schade, A. Mügge, T. Deneke (Bad Neustadt a. d. Saale, Bochum) | ||
| (P1799) | Incidence of silent cerebral lesions after atrial fibrillation ablation is related to periprocedural anticoagulation management | |
| G.-A. Szöllösi, A. Schade, K. Nentwich, J. Krug, P. Müller, U. Emig, M. Roos, R. Schmitt, G. Christopoulos, T. Deneke (Bad Neustadt a. d. Saale) | ||
| (P1800) | Does Silent Cerebral Microembolism Cause Neuropsychological Deficits? Results of a MRI Controlled Multicenter Study? | |
| C. von Bary, T. Arentz, T. Deneke, A. Schade, H. Lehrmann, C. Eissnert, S. Fredersdorf-Hahn, E. Ücer, S. Schwab, C. Wendl, D. Baldaranov, F. Schlachetzki (München, Bad Krozingen, Bad Neustadt a. d. Saale, Regensburg) | ||
| (P1801) | Safety and Feasibility of Left atrial Appendage Occlusion by Cardiac Plug in patients with contraindication to warfarin therapy. A single center experience | |
| S. Fateh-Moghadam, S. Kümpel, A. Henning, J. Schreieck, M. Gawaz, W. Bocksch (Tübingen) | ||
| (P1802) | Rising Prevalence of Atrial Fibrillation in high CHADS2- and CHA2DS2VASc-Scores: Enhanced Monitoring or Anticoagulation? | |
| T. Tischer, R. Schneider, I. Wendig, J. Lauschke, A. Klemm, O. Meyer, D. Diedrich, G. Kundt, D. Bänsch (Rostock) | ||
| (P1803) | Importance of atrial fibrillation as a risk marker for patients with peripheral artery disease | |
| K. Wasmer, J. Köbe, N. Malyar, E. Freisinger, M. Meyborg, L. Eckardt, H. Reinecke (Münster) | ||
| (P1804) | Hypercoagulability Promotes Atrial Fibrosis and Fibrillation | |
| H. Spronk, A.-M. de Jong, S. Verheule, H. de Boer, A. Maass, D. Lau, M. Rienstra, P. W. Kamphuisen, H. ten Cate, H. Crijns, I. Van Gelder, A. J. van Zonneveld, U. Schotten (Maastricht, Groningen, Leiden, NL) | ||
| (P1805) | Atrial fibrillation is a common reason for cryptogenic stroke in patients with cryptogenic stroke: Long term results from a pilot study | |
| S. Kochhäuser, M. Bettin, R. Dittrich, T. Duning, F. Reinke, M. Ritter, D. Dechering, G. Mönnig, L. Eckardt (Münster) | ||
| (P1806) | First follow-up and procedural data of empirical slow pathway modulation in patients presenting with two consecutive AV nodal echo beats. | |
| F. K. Wegner, M. Silvano, N. Bögeholz, G. Frommeyer, D. Dechering, S. Zellerhoff, S. Kochhäuser, P. S. Lange, P. Milberg, J. Köbe, K. Wasmer, G. Mönnig, C. Pott, L. Eckardt (Münster) | ||
| (P1807) | Successful ablation at the left coronary sinus cusp of an accessory pathway at the aortic-mitral continuity. | |
| T. Lin, P. Rausch, E. Wißner, F. Ouyang (Hamburg) |